These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22985195)

  • 21. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.
    Politikos I; Lavery JA; Hilden P; Cho C; Borrill T; Maloy MA; Giralt SA; van den Brink MRM; Perales MA; Barker JN
    Blood Adv; 2020 Jan; 4(1):191-202. PubMed ID: 31935291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation.
    Oostenbrink LVE; Jol-van der Zijde CM; Kielsen K; Jansen-Hoogendijk AM; Ifversen M; Müller KG; Lankester AC; van Halteren AGS; Bredius RGM; Schilham MW; van Tol MJD
    Front Immunol; 2019; 10():315. PubMed ID: 30894854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
    Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ
    Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin.
    Castillo N; García-Cadenas I; Barba P; Canals C; Díaz-Heredia C; Martino R; Ferrà C; Badell I; Elorza I; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):491-497. PubMed ID: 27888015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
    Bejanyan N; Brunstein CG; Cao Q; Lazaryan A; Luo X; Curtsinger J; Mehta RS; Warlick E; Cooley SA; Blazar BR; Miller JS; Weisdorf D; Wagner JE; Verneris MR
    Blood Adv; 2018 Apr; 2(8):909-922. PubMed ID: 29678809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
    Baron F; Storer B; Maris MB; Storek J; Piette F; Metcalf M; White K; Sandmaier BM; Maloney DG; Storb R; Boeckh M
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1176-87. PubMed ID: 17085311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial.
    Admiraal R; Nierkens S; Bierings MB; Bredius RGM; van Vliet I; Jiang Y; Lopez-Yurda M; Versluijs AB; Zwaan CM; Lindemans CA; Boelens JJ
    Lancet Haematol; 2022 Feb; 9(2):e111-e120. PubMed ID: 35114150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.
    Fehse N; Fehse B; Kröger N; Zabelina T; Freiberger P; Krüger W; Kabisch H; Erttmann R; Zander AR
    J Hematother Stem Cell Res; 2003 Apr; 12(2):237-42. PubMed ID: 12804182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.
    Toor AA; Sabo RT; Roberts CH; Moore BL; Salman SR; Scalora AF; Aziz MT; Shubar Ali AS; Hall CE; Meier J; Thorn RM; Wang E; Song S; Miller K; Rizzo K; Clark WB; McCarty JM; Chung HM; Manjili MH; Neale MC
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1237-45. PubMed ID: 25849208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
    Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
    Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
    Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.
    Schmidt-Hieber M; Schwarck S; Stroux A; Ganepola S; Reinke P; Thiel E; Uharek L; Blau IW
    Int J Hematol; 2010 Jun; 91(5):877-85. PubMed ID: 20490728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
    Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F; Zeng D; Higuchi M; Higgins JP; Strober S
    Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.